Skip to content

Merit Medical Systems MMSI Gain/Loss on Asset Sales

Gain/Loss on Asset Sales at other companies

ICU Medical logo
ICU MedicalICUI
-$136K+92.0%
Novanta logo
NovantaNOVT
$248K-94.3%
Nordson logo
NordsonNDSN
$303K+494%

Other financials

Income statement

See full
Revenue$381.9M+7.5%
Gross profit$184.8M+7.4%
Operating income$44.2M+7.6%
Net income$41.0M+36.0%
EPS (diluted)$0.68+38.8%

Balance sheet

See full
Cash & equivalents$488.1M+23.4%
Total debt$821.6M+0.5%
Total equity$1.6B+13.9%
Total assets$2.7B+10.2%

Cash flow

See full
Operating cash flow$40.7M+0.3%
CapEx$16.0M-24.0%
Free cash flow$24.7M+26.5%

Valuation

See full
Market cap$4.01B-34.1%
Enterprise value$4.34B-33.3%
P/E28.8×-21.0×
P/S2.6×-1.8×

Profitability

See full
Gross margin48.7%+0.9pp
Operating margin12.2%+0.6pp
Net margin9%+0.2pp
FCF margin14.3%+1.3pp

Returns & leverage

See full
Return on equity9.1%0.0pp
Debt / equity0.5×-0.1×
Current ratio5.1×+0.2×

Where this comes from

Reported directly by Merit Medical Systems in its filing.

Tagged under the XBRL concept us-gaap:GainLossOnDispositionOfAssets.

The official record: Merit Medical Systems’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Merit Medical Systems's gain/loss on asset sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Merit Medical Systems's gain/loss on asset sales?
Merit Medical Systems (MMSI) reported gain/loss on asset sales of -$67K in Q1 2026.
How has Merit Medical Systems's gain/loss on asset sales changed year-over-year?
Merit Medical Systems's gain/loss on asset sales increased by 23.0% year-over-year, from -$87K to -$67K.
What is the long-term trend for Merit Medical Systems's gain/loss on asset sales?
Over 4 years (2021 to 2025), Merit Medical Systems's gain/loss on asset sales has grown at a 15.3% compound annual growth rate (CAGR), from -$1.3M to -$2.3M.
What does gain/loss on asset sales mean?
Gains or losses on asset disposals removed from operating cash flow — the cash impact is captured in investing activities.